Platinum Equity, a Los Angeles-based global investment firm focused on mergers, acquisitions, and operations, has made a binding offer to acquire Johnson & Johnsons' Chesterbrook, Pennsylvania and Zug, Switzerland-based LifeScan business, which sells the OneTouch line of connected and non-connected glucometers. Platinum Equity will pay $2.1 billion for the business, which reported $1.5 billion in net revenue last year.
from MobiHealthNews http://ift.tt/2FGZ7Kh
March 17, 2018
Rose
MobiHealthNews
No comments
Related Posts:
HHS seeing ‘culture change’ when it comes to data sharingThe U.S. Department of Health and Human Services pledged to share more data between federal departments and with the public, HHS Chief Technology Officer Bruce Greenstein said at HIMSS18 on Wednesday. from MobiHealthNews htt… Read More
Sleep company Eight's latest funding round brings in $14MSleep tracking tech company Eight (formerly known as Luna) has raised $14 million is Series B funding, according to a statement from the company. The round was led by Khosla Ventures, with participation from Y Combinator and … Read More
iTriage, an early mobile health success, shuts down as Aetna preps for new flagship appAetna's iTriage, a symptom checker app that was one of the earliest successful exits in the digital health space, has officially disappeared from the app store after being "sunsetted" to make room for a new, upcoming app call… Read More
New app WeMa aims to give resources to caregiversLondon-based startup WeMa Life has recently launched its online marketplace app that helps caregivers and patients connect with providers. The app has multiple functions and allows caregivers to book social care, domiciliary … Read More
Mayo Clinic finds IBM Watson increases enrollment of clinical trialsThe Mayo Clinic has just released the results of a new study, which show an 80 percent increase in enrollment of clinical trials for breast cancer when using IBM’s Watson for Clinical Trial matching system. The Watson s… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment